Skip to main content
The Execution Platform
Can you run my study?

Operationalize every study
on the same substrate that produced the Executive Summary.

Clinical Intelligence explains the protocol. The Execution Platform operationalizes it across study startup, data collection, monitoring, reconciliation, coding, standards conversion, and submission preparation.

Every operational event runs on the same operating system that produced the Executive Summary. The same evidence model. The same provenance chain. One platform from protocol to submission.

Primary Operators

The teams that actually work on the Execution Platform.

  • CDM Lead
  • Medical Monitor
  • Data Manager
  • Clinical Research Associate
  • Regulatory Lead
  • Statistician
Execution Proof

Where the teams above actually work.

The Study Execution Workspace surfaces every operational dimension of an in-flight study on one screen. Sites. Subjects. Queries. Monitoring. Coding. Reconciliation. Data quality. Amendments. Submission progress. Operators across CDM, Medical Monitoring, CRA, Data Management, Regulatory, and Statistics use the same workspace, scoped to their role.

Study Execution Workspace
Representative · Demo

Representative demonstration. The workspace below illustrates how operators see a real customer's Study Execution surface inside PrismCDM. The values shown are representative for demonstration purposes and do not reflect any specific sponsor study managed by PrismCDM.

Representative Study

Phase 3 study · active mid-execution

The workspace surfaces every operational dimension on one screen. Click any tile to drill into the underlying records. This view updates continuously as operators across sites, monitoring, data management, coding, and reconciliation make decisions.

Study StateWhere the study stands today
Sites
18active

4 activating · 7 planned

Subjects
412enrolled

38 screening · 73 completed

Visits
142this week

487 scheduled · 30 days

Operational WorkloadWhat operators are working on right now
Queries
23open

5 aging · 18 closed this week

Monitoring Tasks
11in flight

3 at risk · 8 on schedule

Coding Queue
47pending

MedDRA + WHODrug

Reconciliation
3exceptions

external lab + safety

Data + AmendmentsData quality and protocol versioning
Data Quality
94%healthy

edit-check pass rate

Amendments
1in review

re-consent + site retraining queued

SDTM Coverage
89%mapped

domain set · v3.4 IG

Submission Progress
Rolls up into the Executive scorecard
Composite Readiness
67/ 100On Track

Accumulated from every site activation, query resolution, signed eCRF, and reconciled record above.

See Executive Scorecard →
Primary Users of This Workspace
  • CDM Lead
  • Medical Monitor
  • Data Manager
  • Clinical Research Associate
  • Regulatory Lead
  • Statistician
Generated
Date
2026-07-15
Engine
Clinical Intelligence Engine v1.2
Workspace Schema
Workspace Schema v3.4
Corpus Snapshot
Public Registry Snapshot 2026-07
Build
v1.6.3

Representative demonstration. The values shown are illustrative of the operational state a real customer's study would surface inside the Execution Workspace. No specific sponsor study is depicted here.

Execution Artifact

Inside the workspace, one domain at a time.

The eCRF Builder is one of many artifacts operators touch inside the workspace. Every CRF field is AI-drafted from the protocol, then reviewed and accepted by the CDM Lead per SDTM domain. Once every field is accepted, the schema is e-signed and locked. The snippet below shows the shape of AE-domain review; the same pattern extends across every other domain the study collects.

eCRF Builder
Representative · Demo

Representative demonstration. The snippet below shows the shape of AE-domain review inside the in-app eCRF Builder. Study identifier and compound name are fictional.

Representative Study

PC-2026-001 · v1.0

Phase I · Oncology · CDASH v2.2
Step 2 of 3 · All 211 fields accepted

CDM Lead e-signature required to publish schema. Once published, the schema is locked; amendments modify fields.

Total Fields
211
generated
Pending Review
0
action required
Accepted
211
CDM Lead approved
Rejected
0
with reason
AE Domain · Field ReviewShowing 4 of 24
  • AEACNAction Taken with Study Treatmentcodelist
    99
    RequiredAccepted
  • AEBODSYSBody System or Organ Classtext
    90
    RequiredAccepted
  • AEDISDid the AE Result in Discontinuation?codelist
    95
    RequiredAccepted
  • AEACNOTHOther Action Takentext
    85
    ExpectedAccepted
Generated
Date
2026-04-24
Engine
CIE v1.2
Standard
CDASH v2.2
Protocol
PC-2026-001 v1.0
Build
v1.6.3

Representative demonstration. Field values are illustrative of the AE-domain review shape PrismCDM composes for customer studies. No specific sponsor study is depicted here.

Execution Outcome

Below the workspace, the executive scorecard.

Submission readiness is not created at the end of a study. It is accumulated throughout execution. Every site activation, every query resolution, every signed eCRF, every reconciled record in the workspace above contributes a measurable increment to the composite readiness score below.

The Submission Readiness Dashboard is what an executive opens to ask “are we ready to submit?”. The workspace is what their teams open to make sure the answer is yes.

Submission Readiness
Representative · Demo

Representative demonstration. The structure below illustrates how a real customer's Submission Readiness Dashboard renders inside PrismCDM. The values shown are representative for demonstration purposes and do not reflect any specific sponsor study managed by PrismCDM.

Representative Study

Phase 3 study in mid-execution

The dashboard reflects a representative Phase 3 study several months into execution. Specific operational counts, scores, and dates are illustrative.

Submission Readiness Assessment
Submission Readiness Score (representative)
Composite readiness derived from protocol intelligence, study execution, clinical data quality, evidence generation, provenance integrity, and regulatory completeness.
73/ 100
On Track
Blocking Items (representative)
  • High3
  • Medium7
  • Low12
Next Required Actions (representative)
  • Resolve SDTM mapping validation
  • Complete medical coding review
  • Finalize protocol amendment
Study ProgressStructural view · representative
  1. Protocol
  2. Clinical Intelligence
  3. Study Execution
  4. Clinical Data
  5. Evidence Generation
  6. Regulatory Submission
Platform Readiness by Capability (representative)
Clinical Intelligence
Complete
100%

Trial Intelligence complete; findings + recommendations issued.

Execution
In Progress
67%

Operational workflow in progress: sites activated, monitoring active, data capture ongoing.

Evidence
In Progress
41%

Inspection Evidence Package accumulating continuously from operational events.

Provenance & Explainability
Complete
100%

Every finding, recommendation, and operational event traceable through the provenance chain.

Next milestone (representative)
First evidence package draft
Generated
Date
2026-07-15
Engine
Clinical Intelligence Engine v1.2
Assessment
PTII Assessment v1
Corpus Snapshot
Public Registry Snapshot 2026-07
Build
v1.6.3

Representative demonstration. The values shown are illustrative of the dashboard structure PrismCDM renders for customer studies. No specific sponsor study is depicted here.

Intelligence without execution

is just analysis.

Every recommendation connects to a concrete operational action. Every operational event is traceable back to its source.

Early Access

See how Intelligence becomes operational decisions.

Bring one of your protocols. We'll generate the Executive Summary and walk every recommendation through to the operational decisions a real CDM Lead, Medical Monitor, and Site team would make on the Execution Platform.